Menu
This is a preorder. Volume 43A will be available January 2027. Volume 43B will be available July 2027.
Expiration dates to claim credit:
Volume 43A: 1/31/2028
Volume 43B: 7/31/2028
Don't have time to read numerous journals? Discover emerging... Read More +
The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Anesthesiologists designates this enduring material for a maximum of 60 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification in Anesthesiology® and MOCA® are registered certification marks of the American Board of Anesthesiology®. Please consult the ABA website, www.theABA.org, for a list of all MOCA requirements.
The number of credits that may contribute to the Patient Safety CME component of the American Board of Anesthesiology’s Maintenance of Certification in Anesthesiology® (MOCA®) program will be determined closer to publication of the program.
Credit for Canadian MOC Participants: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program. Visit the ACCME website for more information.
For information on other accreditations, contact ASA Member Services at (847) 825-5586.
After successfully completing this activity, the learner will be able to:
Summaries of Emerging Evidence Editorial Board
Amy C. Robertson, MD, Editor-in-Chief
Nashville, Tennessee
Neil A. Hanson, MD, Medical Editor
Edina, Minnesota
Alyssa B. Brzenski, MD, FASA
San Diego, California
Gloria Cheng, MD
Dallas, Texas
Sung “Jason” Chi, MD
Mountain View, California
John R. Coleman, MD
Aylett, Virginia
Kristyn B. Ingram, MD, FASA
El Paso, Texas
Kelly Ivins-O’Keefe, MD
San Antonio, Texas
Aaron N. Primm, MD, FASA
New York, New York
Naileshni S. Singh, MD
Sacramento, California
Alex T. Suginaka, DO
Wausau, Wisconsin
Adam L. Wendling, MD
Gainesville, Florida
ASA Staff: Kari L. Lee, Senior Managing Editor; Ginger Clark, Managing Editor; Rachel Winokur, Senior Editor; Mark Grant, MD, PhD, Methodologist
The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists’ educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The following SEE faculty, staff, and/or planning committee members have indicated that they have relationships with ineligible companies to disclose:
Ginger Clark
Merck & Co, Inc—Stock
Organon & Co—Stock
All relevant financial relationships for this activity have been mitigated.
All other planners, faculty, and staff have reported no relevant financial relationships with ineligible companies to disclose.
You do not have to make a payment at this time, but you can reach out to your practice/group leader to find out when they plan to pay your dues. Email or call the ASA Support team for assistance: (630) 912-2552 or info@asahq.org.
